UNSPSC 51152026: Denpidazone

This classification denotes a muscle relaxant with the molecular formula C20H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7N3FX2T1J, chemically known as 3,6-pyridazinedione, 1,2-dihydro-4-butyl-5-hydroxy-1,2-diphenyl- but generally known as denpidazone, which bears US NIH Compound Identifier 206004. European Medicines Agency schedules Denpidazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06979MIG.

UNSPSC 51152026 Denpidazone, a Commodity code, appears to be misaligned with the state and local opportunities currently posted under this code. The recent solicitations involve naloxone procurement and direct-to-manufacturer prescription programs — neither of which corresponds to denpidazone, a pharmaceutical active ingredient used in antiparasitic formulations. State and local governments are not actively soliciting denpidazone itself under this code designation. The code shows minimal relevant recent activity; the posted opportunities do not reflect the commodity's nominal scope.

The two opportunities tagged to this code reflect prescription-benefit management and emergency-response pharmaceuticals rather than the specific active pharmaceutical ingredient the code purports to cover. Seminole County, Florida (IFB60459723LAS, posted June 30, 2026, response due July 26, 2023) solicited naloxone and drug deactivation systems for community health support, while the Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) gathered vendor information on direct-to-manufacturer prescription contracting models. No state or local procurement activity directly targeting denpidazone is evident in the available record. Vendors evaluating this code should verify whether the UNSPSC taxonomy assignment reflects procurement intent or a data-entry error before committing resources to pursuits under this designation.